Cargando…

Supervoxels-Based Histon as a New Alzheimer’s Disease Imaging Biomarker

Alzheimer’s disease (AD) represents the prevalent type of dementia in the elderly, and is characterized by the presence of neurofibrillary tangles and amyloid plaques that eventually leads to the loss of neurons, resulting in atrophy in specific brain areas. Although the process of degeneration can...

Descripción completa

Detalles Bibliográficos
Autores principales: Toro, César A. Ortiz, Gonzalo-Martín, Consuelo, García-Pedrero, Angel, Menasalvas Ruiz, Ernestina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022184/
https://www.ncbi.nlm.nih.gov/pubmed/29844294
http://dx.doi.org/10.3390/s18061752
_version_ 1783335625592668160
author Toro, César A. Ortiz
Gonzalo-Martín, Consuelo
García-Pedrero, Angel
Menasalvas Ruiz, Ernestina
author_facet Toro, César A. Ortiz
Gonzalo-Martín, Consuelo
García-Pedrero, Angel
Menasalvas Ruiz, Ernestina
author_sort Toro, César A. Ortiz
collection PubMed
description Alzheimer’s disease (AD) represents the prevalent type of dementia in the elderly, and is characterized by the presence of neurofibrillary tangles and amyloid plaques that eventually leads to the loss of neurons, resulting in atrophy in specific brain areas. Although the process of degeneration can be visualized through various modalities of medical imaging and has proved to be a valuable biomarker, the accurate diagnosis of Alzheimer’s disease remains a challenge, especially in its early stages. In this paper, we propose a novel classification method for Alzheimer’s disease/cognitive normal discrimination in structural magnetic resonance images (MRI), based on the extension of the concept of histons to volumetric images. The proposed method exploits the relationship between grey matter, white matter and cerebrospinal fluid degeneration by means of a segmentation using supervoxels. The calculated histons are then processed for a reduction in dimensionality using principal components analysis (PCA) and the resulting vector is used to train an support vector machine (SVM) classifier. Experimental results using the OASIS-1 database have proven to be a significant improvement compared to a baseline classification made using the pipeline provided by Clinica software.
format Online
Article
Text
id pubmed-6022184
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-60221842018-07-02 Supervoxels-Based Histon as a New Alzheimer’s Disease Imaging Biomarker Toro, César A. Ortiz Gonzalo-Martín, Consuelo García-Pedrero, Angel Menasalvas Ruiz, Ernestina Sensors (Basel) Article Alzheimer’s disease (AD) represents the prevalent type of dementia in the elderly, and is characterized by the presence of neurofibrillary tangles and amyloid plaques that eventually leads to the loss of neurons, resulting in atrophy in specific brain areas. Although the process of degeneration can be visualized through various modalities of medical imaging and has proved to be a valuable biomarker, the accurate diagnosis of Alzheimer’s disease remains a challenge, especially in its early stages. In this paper, we propose a novel classification method for Alzheimer’s disease/cognitive normal discrimination in structural magnetic resonance images (MRI), based on the extension of the concept of histons to volumetric images. The proposed method exploits the relationship between grey matter, white matter and cerebrospinal fluid degeneration by means of a segmentation using supervoxels. The calculated histons are then processed for a reduction in dimensionality using principal components analysis (PCA) and the resulting vector is used to train an support vector machine (SVM) classifier. Experimental results using the OASIS-1 database have proven to be a significant improvement compared to a baseline classification made using the pipeline provided by Clinica software. MDPI 2018-05-29 /pmc/articles/PMC6022184/ /pubmed/29844294 http://dx.doi.org/10.3390/s18061752 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Toro, César A. Ortiz
Gonzalo-Martín, Consuelo
García-Pedrero, Angel
Menasalvas Ruiz, Ernestina
Supervoxels-Based Histon as a New Alzheimer’s Disease Imaging Biomarker
title Supervoxels-Based Histon as a New Alzheimer’s Disease Imaging Biomarker
title_full Supervoxels-Based Histon as a New Alzheimer’s Disease Imaging Biomarker
title_fullStr Supervoxels-Based Histon as a New Alzheimer’s Disease Imaging Biomarker
title_full_unstemmed Supervoxels-Based Histon as a New Alzheimer’s Disease Imaging Biomarker
title_short Supervoxels-Based Histon as a New Alzheimer’s Disease Imaging Biomarker
title_sort supervoxels-based histon as a new alzheimer’s disease imaging biomarker
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022184/
https://www.ncbi.nlm.nih.gov/pubmed/29844294
http://dx.doi.org/10.3390/s18061752
work_keys_str_mv AT torocesaraortiz supervoxelsbasedhistonasanewalzheimersdiseaseimagingbiomarker
AT gonzalomartinconsuelo supervoxelsbasedhistonasanewalzheimersdiseaseimagingbiomarker
AT garciapedreroangel supervoxelsbasedhistonasanewalzheimersdiseaseimagingbiomarker
AT menasalvasruizernestina supervoxelsbasedhistonasanewalzheimersdiseaseimagingbiomarker